Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs Philip Morris International Inc. (PM) Price & Performance

Moderna, Inc.Trade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Philip Morris International Inc. — how do they compare? Moderna, Inc. trades at $60.53 (market cap $24.18B), while Philip Morris International Inc. trades at $185.75 (market cap $290.24B). The key difference: Philip Morris International Inc. is far larger — about 12× Moderna, Inc.'s market cap, and Philip Morris International Inc. pays a 3.16% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.

MRNAPM
Market Cap
$24.18B$290.24B
Sector
HealthConsumer Staples
52-Week High
$81.80$200.17
52-Week Low
$22.36$144.33
Enterprise Value
$20.33B$333.36B
Dividend Yield
3.16%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Moderna, Inc.

No Aura AI signal available yet.

Philip Morris International Inc.

Philip Morris International (PM) trades at $186.22, down 1.77% with mixed technical signals. The company reported strong Q1 and Q2 2026 earnings beats but faces margin pressure from rising costs. Revenue grew to $40.65B in 2025 with a robust 25.56% net income margin. Analyst consensus remains bullish with a $211.17 price target, though recent news highlights challenges including a $500M impairment charge and increased illicit cigarette trade in Europe.

PM offers solid fundamentals with high profitability and dividend yield, but near-term headwinds from cost inflation and regulatory risks warrant caution. The stock's valuation at 25.54x P/E is reasonable given earnings growth potential, making it attractive for long-term investors despite current volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM